-

Artificial Intelligence for Healthcare IT, Worldwide, 2020 - Benchmarking Future Growth Potential - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Artificial Intelligence for Healthcare IT, Global, 2020" report has been added to ResearchAndMarkets.com's offering.

This research has identified the core areas in which artificial intelligence (AI)-enabled healthcare IT solutions are most relevant for hospitals, physicians, and payers.

Hospitals that have so far invested in AI-based financial solutions to automate patient access management, reimbursement eligibility matching, and computer-assisted coding are now also preferring clinical-grade AI solutions for imaging analytics, genomics profiling, clinical risk stratification, and precision medicine-based diagnosis.

Physician practices continue to focus on automated, AI-based healthcare IT solutions that perform practice management, physician scheduling, and workforce attribution. Large group practices are investing in conversational AI solutions that engage and activate patients via chatbot. AI also allows practice management software to merge with a third-party electronic medical record (EMR) or population health management platform for effective referral management and patient tracking in their journey across the care continuum.

The payer market, one of the biggest investors in AI-based healthcare IT solutions, is betting big on enterprise-grade AI platforms that predict epidemics (such as COVID-19), forecast patient volume across their member providers, authenticate reimbursement, and drive general well-being of the insured population through medication management and self-care enablement.

Other stakeholders are emerging, too. Government agencies, patients, incubators, academic medical centers, large healthcare IT vendors, and institutional investors are playing important roles in helping this technology gain traction in the global healthcare market.

The report reveals the market positioning of companies in an industry using their Growth and Innovation scores as highlighted in the methodology. The document presents competitive profiles on each of the companies in the report based on their strengths, opportunities, and a small discussion on their positioning.

The analyst analyzes hundreds of companies in the industry and benchmarks them across 10 criteria on the report, where the leading companies in the industry are then positioned. Industry leaders on both the Growth and Innovation indices are recognized as best practice recipients.

Key Topics Covered

1. Strategic Imperative and Growth Environment

  • Strategic Imperative
  • Growth Environment

2. Companies to Action

  • Allscripts
  • Amazon Web Services
  • Apple
  • Change Healthcare
  • GE Healthcare
  • Google
  • Health Catalyst
  • HP Systems
  • IBM Watson Health
  • Inovalon
  • Intel
  • Medial Early Sign
  • Microsoft
  • Nuance
  • Optum
  • Philips Healthcare
  • Qure.ai
  • Salesforce
  • SigTuple
  • Wolters Kluwer

3. Strategic Insights

4. Next Steps: Leveraging the Radar to Empower Key Stakeholders

  • Significance of Being on the Report
  • Empowers the CEO's Growth Team
  • Empowers Investors
  • Empowers Customers
  • Empowers the Board of Directors

5. Analyst Analytics

  • Benchmarking Future Growth Potential

For more information about this report visit https://www.researchandmarkets.com/r/8jh0u

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Vertigo Drugs Market Outlook Report 2026-2034 - Landscape Shift Towards Targeted Drug Regimens Over Blanket Suppression, Emphasizing Early Rehab and Non-Sedating Prophylactics - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Vertigo Drugs Market Outlook 2026-2034: Market Share, and Growth Analysis" has been added to ResearchAndMarkets.com's offering. The Vertigo Drugs Market is projected to grow significantly, with a valuation of USD 1.66 billion in 2025 and targeted to reach USD 2.38 billion by 2034 at a CAGR of 3.9%. This market covers the pharmacologic management of various vestibular disorders within multiple medical settings, including ENT, neurology, and primary care. Core applic...

Trends Shaping the $5 Billion Spasticity Treatment Market, 2026-2034: Focus on Multimodal Care and Treatment Innovations - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Spasticity Treatment Market Outlook 2026-2034: Market Share, and Growth Analysis" has been added to ResearchAndMarkets.com's offering. The global Spasticity Treatment Market, valued at USD 5.02 billion in 2025, is set to expand at a CAGR of 5.5%, reaching USD 8.13 billion by 2034. This growth is driven by innovations in pharmacologic therapies, interventional procedures, and multimodal rehabilitative modalities designed to manage spasticity associated with various...

Intracranial Aneurysm Market and Competition Outlook 2026-2034: Market Share, Growth Analysis, Strategic Initiatives and Emerging Trends - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Intracranial Aneurysm Market Outlook 2026-2034: Market Share, and Growth Analysis" has been added to ResearchAndMarkets.com's offering. The Intracranial Aneurysm Market, valued at USD 1.79 billion in 2025, is forecasted to grow at a CAGR of 10% to reach USD 4.22 billion by 2034. Trends indicate enhanced demand for low-profile flow diverters, resheathable delivery systems, and AI-assisted aneurysm detection, propelled by the global incidence of subarachnoid hemorrha...
Back to Newsroom